SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Vivanza Biosciences Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
530057 INE984E01035 1.2368 Not Listed 0 8.48 0 0 1
Quarters :
ParticularsMar 2025(Rs.Cr)Dec 2024(Rs.Cr)Sep 2024(Rs.Cr)
Gross Sales0.170.761.58
Other Operating Income0.000.000.00
Other Income 0.020.010.00
Total Income0.190.771.59
Total Expenditure 1.070.641.48
PBIDT-0.880.130.10
Interest 0.080.090.09
PBDT-0.960.040.01
Depreciation0.000.000.00
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax-0.970.040.01
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-0.970.040.01
    
EPS (Unit Curr.)-0.240.010.00
EPS (Adj) (Unit Curr.)-0.240.010.00
Calculated EPS (Unit Curr.)-0.240.010.00
Calculated EPS (Adj) (Unit Curr.)-0.240.010.00
Calculated EPS (Ann.) (Unit Curr.)-0.970.040.01
Calculated EPS (Adj) (Ann.) (Unit Curr.)-0.970.040.01
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity4.004.004.00
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)-517.6517.116.33
PBDTM(%)-564.715.260.63
PATM(%)-570.595.260.63